Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Evotec CEO resigns

This article was originally published in Scrip

Executive Summary

Jörn Aldag is to resign as president and CEO of Evotecat the end of the year. The company will be co-led by Dr Mario Polywka, currently chief operating officer, and Dr Klaus Maleck, chief financial officer, until a permanent successor is found. Mr Aldag has been with Evotec for 11 years and has overseen the company's transformation from a technology provider to a CNS-focused biopharmaceutical company.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts